Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 
David F.  Penson

David F. Penson, M.D., M.P.H.

Chair, Department of Urologic Surgery
Paul V. Hamilton, MD and Virginia E. Howd Professor of Urologic Oncology
Co-Leader, Cancer Health Outcomes and Control Research Program
Director, Center for Surgical Quality and Outcomes Research
Urologic Surgeon/Oncologist

  • Appointments
    615-322-2880
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Nashville Veterans Affairs Medical Center
    615-327-4751

    Office
    615-343-1529
  • Faxes
    Nashville Veterans Affairs Medical Center Fax
    615-873-7901
    Office Fax
    615-875-2655
    Clinic Fax
    615-343-9815
  • Addresses
    Nashville Veterans Affairs Medical Center
    1310 24th Ave. South
    Nashville , TN 37212-2637
    Website

    Office
    Vanderbilt University Medical Center
    2525 West End Avenue, Suite 1200
    Nashville, TN 37203-1738
Profile

Dr. Penson is a board-certified urologic oncologist who focuses on urological malignancies, particularly bladder and prostate cancer. He is an internationally recognized expert in the care of both of these common cancers and is also a federally funded researcher with a focus on patient-reported outcomes, survivorship and comparative effectiveness in prostate cancer. He serves as the American Urologic Association National Chair for Healthcare Policy and is the organization's representative to the Commission on Cancer.

Education
  • M.D. - Boston University, 1991
  • M.P.H. - Yale University, 2000
Postgraduate Training
  • General Surgery Internship - UCLA Health System, 1992
  • General Surgery Residency - UCLA Health System, 1993
  • Urology Residency - UCLA Health System, 1997
  • Fellowship - Yale University School of Medicine, 1999
Clinical Research Description

My primary research interest has been in using population-based cohorts and assessing patient-reported outcomes in conditions treated with surgical procedures, specifically prostate cancer. My additional interests include (but are not limited to) cost-effectiveness analyses, exploring disparities in access and quality of care across numerous surgical conditions. I also maintain a focus on improving clinical decision-making.

Publications